Daito Pharmaceutical Co.,Ltd.
ダイト株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4577
FY2025 · 2026-05-31
| Gross margin | 19.5% |
| Operating margin | 7.2% |
| Net margin | 6.2% |
| Return on equity | 6.2% |
| Return on assets | 4.3% |
| Revenue growth (YoY) | 0.0% |
| EPS (basic) | ¥107.49 |
| EPS growth (YoY) | 71.3% |
| Current ratio | 2.62x |
| Equity ratio | 69.7% |
| Book value / share | ¥1,840.13 |
| Free cash flow | 5,559 M |